Impetux Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $2.92M

  • Investors
  • 2

Impetux General Information

Description

Operator of an optical tweezers system designed for mechanobiology studies in living cells and 3D tissues. The company's system offers features like optical trap generation and simultaneous calibration-free force measurements, analysis of light momentum changes, and other related features, enabling researchers to access the platform to manipulate individual cells or cell organelles like nuclei and membranes.

Contact Information

Website
www.impetux.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Ferran Puig 13
  • 08023 Barcelona
  • Spain
+34 931
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Ferran Puig 13
  • 08023 Barcelona
  • Spain
+34 931

Impetux Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Impetux Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 30-Apr-2026 $2.92M Completed Generating Revenue
3. Secondary Transaction - Private 01-Jul-2024 Completed Generating Revenue
2. Equity Crowdfunding 01-Jan-2016 $136K $136K Completed Generating Revenue
1. University Spin-Out 07-May-2012 Completed Generating Revenue
To view Impetux’s complete valuation and funding history, request access »

Impetux Patents

Impetux Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4043860-A1 Method and device for performing microrheological measurements in a viscoelastic medium Active 15-Feb-2021
US-20230384196-A1 Method and device for performing microrheological measurements in a viscoelastic medium Active 15-Feb-2021
WO-2022171898-A1 Method and device for performing microrheological measurements in a viscoelastic medium Inactive 15-Feb-2021
EP-4043860-B1 Method for performing microrheological measurements in a viscoelastic medium Active 15-Feb-2021
EP-4043860-C0 Method for performing microrheological measurements in a viscoelastic medium Active 15-Feb-2021 G01N11/16
To view Impetux’s complete patent history, request access »

Impetux Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Impetux Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Bullnet Capital Venture Capital Minority
Universitat de Barcelona Corporation
To view Impetux’s complete investors history, request access »

Impetux FAQs

  • When was Impetux founded?

    Impetux was founded in 2012.

  • Where is Impetux headquartered?

    Impetux is headquartered in Barcelona, Spain.

  • What is the size of Impetux?

    Impetux has 7 total employees.

  • What industry is Impetux in?

    Impetux’s primary industry is Discovery Tools (Healthcare).

  • Is Impetux a private or public company?

    Impetux is a Private company.

  • What is Impetux’s current revenue?

    The current revenue for Impetux is .

  • How much funding has Impetux raised over time?

    Impetux has raised $3.06M.

  • Who are Impetux’s investors?

    Bullnet Capital and Universitat de Barcelona have invested in Impetux.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process